Friday, February 17, 2006


Hepatitis C - AVI BioPharma Announces Hepatitis C Virus License Agreement with


AVI BioPharma Announces Hepatitis C Virus License Agreement with
dBusinessNews.com - Offering comprehensive Web design services to new economy enterprises across a wide range of platforms and technologies, Web Design Studio takes pride in delivering big-business Internet solutions to small and medium-sized businesses. PORTLAND -- AVI

Molecular mechanism that inhibits HCV replication discovered - Tang
RxPG - By Florida State University, The hepatitis C virus (HCV) infects more than 170 million people worldwide and leads to both acute and chronic liver diseases. Since its discovery several decades ago, the insidious human pathogen has stymied the quest

Hepatitis C Recurs Rapidly After Liver Transplant
Medical News Today - When a diseased liver is removed from a patient with Hepatitis C (HCV), serum viral levels plummet. However, after receiving a healthy liver transplant, virus levels rebound and can surpass pre-transplant levels within a few days, according to a new

Alnylam Pharmaceuticals Reports Fourth Quarter and Year End 2005
Genetic Engineering News - Through December 31, 2005, Alnylam had financed $8.2 million of its capital expenditures under its $10.0 million equipment line of credit with Lighthouse Capital Partners V, L.P. The company's ability to draw down on this line of credit ended on

Home paper shredders pose serious injury risk to toddlers
RxPG - By New York University Medical Center and School of Medicine, As our environments change over time with technology, pediatric emergency specialists are continuously challenged to observe possible trends and prevent more injuries by educating the